Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. A. Ferrante
Chemical Screen Identifies FDA-approved Drugs and Target Pathways That Induce Precocious Pancreatic Endocrine Differentiation
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Identification of FDA-approved Drugs That Computationally Bind to MDM2
Chemical Biology and Drug Design
Biochemistry
Organic Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
Repurposing FDA-approved Drugs for Anti-Aging Therapies
Biogerontology
Aging
Gerontology
Geriatrics
Possible FDA-approved Drugs to Treat Ebola Virus Infection
Infectious Diseases of Poverty
Medicine
Environmental
Public Health
Infectious Diseases
Occupational Health
A Review on the Drugs Approved by US-FDA and DCGI
TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
Drug Development Process and Novel Drugs Approved by FDA for 2017 -18
Applied Clinical Research, Clinical Trials and Regulatory Affairs
Proinflammatory Cytokines Induce Endocrine Differentiation in Pancreatic Ductal Cells via STAT3-Dependent NGN3 Activation
Cell Reports
Biochemistry
Genetics
Molecular Biology
Quantitative Analysis on the Characteristics of Targets With FDA Approved Drugs
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium Parvum Growth
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
